Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low ‐grade glioma

In conclusion, bevacizumab is well tolerated and appears most effective for rapid tumor control to preserve vision and improve morbidity.

Source: Cancer Medicine - December 19, 2018 Category: Cancer & Oncology Authors: Nataliya Zhukova, Revathi Rajagopal, Adrienne Lam, Lee Coleman, Peter Shipman, Thomas Walwyn, Molly Williams, Michael Sullivan, Martin Campbell, Kanika Bhatia, Nicholas G. Gottardo, Jordan R. Hansford Tags: ORIGINAL RESEARCH Source Type: research